Rachel E. Klevit

Rachel E. Klevit

Auto-generated profile, based on publicly available information

Rachel E. Klevit

Department of Biochemistry, University of Washington, Seattle, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
MMMeredith B. Metzger
Meredith B. Metzger
JPJonathan N. Pruneda
Jonathan N. Pruneda
RKRachel E. Klevit
Rachel E. Klevit
AWAllan M. Weissman
Allan M. Weissman

22 March 2016 in Cell Research
Verified
Journal Article
Open access
PDF file
MSMikaela D Stewart
Mikaela D Stewart
TRTobias Ritterhoff
Tobias Ritterhoff
RKRachel E Klevit
Rachel E Klevit
PBPeter S Brzovic
Peter S Brzovic
Ubiquitin-conjugating enzymes (E2s) are the central players in the trio of enzymes responsible for the attachment of ubiquitin (Ub) to cellular proteins. Humans have ∼40 E2s that are involved in the transfer of Ub or Ub-like (Ubl) proteins (e.g., SUMO and NEDD8). Although the majority of E2s are only twice the size of Ub, this remarkable family of enzymes performs a variety of functional roles. In this review, we summarize common functional and structural features that define unifying themes among E2s and highlight emerging concepts in the mechanism and regulation of E2s.

1 May 2011 in Nature
Verified
Journal Article
Open access
PDF file
DWDawn M. Wenzel
Dawn M. Wenzel
ALAlexei Lissounov
Alexei Lissounov
PBPeter S. Brzovic
Peter S. Brzovic
RKRachel E. Klevit
Rachel E. Klevit
Attachment of the small protein ubiquitin (Ub) to substrates is a reversible covalent modification that regulates the stability, activity and localization of target proteins. Assembly of ubiquitin chains requires three enzyme activities: a Ub-activating (E1) enzyme, a Ub-conjugating (E2) enzyme and a Ub ligase (E3). E2 enzymes are responsible both for E3 selection and substrate modification and for much of the diversity of Ub cellular signalling. The E2 UbcH7 shows broad specificity for HECT-type E3, but often fails to function with RING E3s despite its ability to form specific complexes. Rachel Klevit and colleagues demonstrate that UbcH7 exhibits robust activity with a family of E3 ligases that are RING/HECT hybrids: they bind to E2s through a RING domain but transfer Ub through a HECT-like mechanism. They propose that the intrinsic chemical reactivity of an E2 is a powerful predictor in determining with which class of E3 it will function. Although the functional interaction between ubiquitin-conjugating enzymes (E2s) and ubiquitin ligases (E3s) is essential in ubiquitin (Ub) signalling, the criteria that define an active E2–E3 pair are not well established. The human E2 UBCH7 (also known as UBE2L3) shows broad specificity for HECT-type E3s1, but often fails to function with RING E3s in vitro despite forming specific complexes2,3,4. Structural comparisons of inactive UBCH7–RING complexes with active UBCH5–RING complexes reveal no defining differences3,4, highlighting a gap in our understanding of Ub transfer. Here we show that, unlike many E2s that transfer Ub with RINGs, UBCH7 lacks intrinsic, E3-independent reactivity with lysine, explaining its preference for HECTs. Despite lacking lysine reactivity, UBCH7 exhibits activity with the RING-in-between-RING (RBR) family of E3s that includes parkin (also known as PARK2) and human homologue of ariadne (HHARI; also known as ARIH1)5,6. Found in all eukaryotes7, RBRs regulate processes such as translation8 and immune signalling9. RBRs contain a canonical C3HC4-type RING, followed by two conserved Cys/His-rich Zn2+-binding domains, in-between-RING (IBR) and RING2 domains, which together define this E3 family7. We show that RBRs function like RING/HECT hybrids: they bind E2s via a RING domain, but transfer Ub through an obligate thioester-linked Ub (denoted ∼Ub), requiring a conserved cysteine residue in RING2. Our results define the functional cadre of E3s for UBCH7, an E2 involved in cell proliferation10 and immune function11, and indicate a novel mechanism for an entire class of E3s.

1 September 2012 in Molecular Cell
Verified
Journal Article
Closed access
JPJonathan N. Pruneda
Jonathan N. Pruneda
PLPeter J. Littlefield
Peter J. Littlefield
SSSarah E. Soss
Sarah E. Soss
KNKyle A. Nordquist
Kyle A. Nordquist
WCWalter J. Chazin
Walter J. Chazin
RKRachel E. Klevit
Rachel E. Klevit

5 May 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PBPeter S. Brzovic
Peter S. Brzovic
JKJennifer R. Keeffe
Jennifer R. Keeffe
HNHiroyuki Nishikawa
Hiroyuki Nishikawa
KMKeiko Miyamoto
Keiko Miyamoto
DFDavid Fox
David Fox
RKRachel Klevit
Rachel Klevit
BRCA1 is a breast and ovarian cancer tumor suppressor protein that associates with BARD1 to form a RING/RING heterodimer. The BRCA1/BARD1 RING complex functions as an ubiquitin (Ub) ligase with activity substantially greater than individual BRCA1 or BARD1 subunits. By using NMR spectroscopy and site-directed mutagenesis, we have mapped the binding site on the BRCA1/BARD1 heterodimer for the Ub-conjugating enzyme UbcH5c. The results demonstrate that UbcH5c binds only to the BRCA1 RING domain and not the BARD1 RING. The binding interface is formed by the first and second Zn 2+ -loops and central α-helix of the BRCA1 RING domain, a region disrupted by cancer-predisposing mutations. Unexpectedly, a second Ub-conjugating enzyme, UbcH7, also interacts with the BRCA1/BARD1 complex with similar affinity, although it is not active in Ub-ligase activity assays. Thus, binding alone is not sufficient for BRCA1-dependent Ub-ligase activity.

29 August 2010 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
SJStefan Jehle
Stefan Jehle
PRPonni Rajagopal
Ponni Rajagopal
BBBenjamin Bardiaux
Benjamin Bardiaux
SMStefan Markovic
Stefan Markovic
RKRonald Kühne
Ronald Kühne
HOHartmut Oschkinat
Hartmut Oschkinat